Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nacilla Haicheur

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patientsOlivier Adotevi, Helene Pere, Patrice Ravel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunityOlivier Adotevi, Benoit Vingert, Ludovic Freyburger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Prognostic and predictive values of the immunoscore in patients with rectal cancerMaria-Gabriela Anitei, Guy Zeitoun, Bernhard Mlecnik, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patientsNadege Bercovici, Nacilla Haicheur, Severine Massicard, et al.
The Journal of Pathology. Clinical Research|September 9, 2020
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and ImmunoscorePamela Baldin, Marc Van den Eynde, Bernhard Mlecnik, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancerFlorence Marliot, Xiaoyi Chen, Amos Kirilovsky, et al.
Oncotarget|January 12, 2022
The "Immunoscore" in rectal cancer: could we search quality beyond quantity of life?Amos Kirilovsky, Carine El Sissy, Guy Zeitoun, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapyElodie Lauret Marie Joseph, Amos Kirilovsky, Benoît Lecoester, et al.
Journal of the National Cancer Institute|September 20, 2017
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on SurvivalBernhard Mlecnik, Marc Van den Eynde, Gabriela Bindea, et al.
Cancer Cell|December 12, 2018
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer PatientsMarc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patientsOlivier Adotevi, Helene Pere, Patrice Ravel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunityOlivier Adotevi, Benoit Vingert, Ludovic Freyburger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Prognostic and predictive values of the immunoscore in patients with rectal cancerMaria-Gabriela Anitei, Guy Zeitoun, Bernhard Mlecnik, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patientsNadege Bercovici, Nacilla Haicheur, Severine Massicard, et al.
The Journal of Pathology. Clinical Research|September 9, 2020
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and ImmunoscorePamela Baldin, Marc Van den Eynde, Bernhard Mlecnik, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancerFlorence Marliot, Xiaoyi Chen, Amos Kirilovsky, et al.
Oncotarget|January 12, 2022
The "Immunoscore" in rectal cancer: could we search quality beyond quantity of life?Amos Kirilovsky, Carine El Sissy, Guy Zeitoun, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapyElodie Lauret Marie Joseph, Amos Kirilovsky, Benoît Lecoester, et al.
Journal of the National Cancer Institute|September 20, 2017
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on SurvivalBernhard Mlecnik, Marc Van den Eynde, Gabriela Bindea, et al.
Cancer Cell|December 12, 2018
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer PatientsMarc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, et al.
Pageof 3